<DOC>
	<DOCNO>NCT01189318</DOCNO>
	<brief_summary>In study , patient major depressive disorder ( MDD ) insomnia symptom treat Seroquel XR open-label manner 4-week period repeat measurement insomnia symptom sleep parameter use polysomnography .</brief_summary>
	<brief_title>Effects Seroquel XR Sleep Architecture Patients With Major Depressive Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>Patient Men woman age 20 65 Diagnosis major depressive disorder assess Structured Clinical Interview DSMIV ( SCIDIV ) A score 1 great sleep item ( item 4 , 5 , 6 ) Hamilton Depression Rating Scale ( HDRS ) Provision write informed consent Healthy Control Subject Healthy Men Women age 20 65 Provision write informed consent Presence major physical neurological illness ( e.g.，head trauma， epilepsy，seizure，stroke，cerebral tumor，multiple sclerosis，cerebrovascular disease , narrowangle glaucoma , drug hypersensitivity，etc . ) Diagnosis Axis I disorder major depressive disorder presence symptom require hospitalization Drug abuse past 3 month Women pregnant，breastfeeding , plan pregnancy Contraindications drug use study ( e.g. , allergy , intolerance , etc . ) Unstable medical illness severe abnormality laboratory test screen assessment Increase blood glucose , lipid , calcium level screen Low blood pressure screen assessment Intelligence quotient 80 Use follow cytochrome P450 3A4 inhibitor 14 day precede enrolment include limited : ketoconazole , itraconazole , fluconazole , erythromycin , clarithromycin , troleandomycin , indinavir , nelfinavir , ritonavir , fluvoxamine saquinavir Use follow cytochrome P450 3A4 inducer 14 day precede enrolment include limited : phenytoin , carbamazepine , barbiturate , rifampin , St. John 's Wort , glucocorticoid Administration depot antipsychotic injection within one dose interval ( depot ) randomisation Substance alcohol dependence enrolment ( except dependence full remission , except caffeine nicotine dependence ) , define DSMIV criterion Opiates , amphetamine , barbiturate , cocaine , cannabis , hallucinogen abuse DSMIV criterion within 3 month prior enrolment Previous enrolment randomisation treatment present study . Participation another drug trial within 4 week prior enrolment study long accordance local requirement Medical condition would affect absorption , distribution , metabolism , excretion study treatment A patient Diabetes Mellitus An absolute neutrophil count ( ANC ) &lt; = 1.5 x 10^9 per liter Insomnia cause medical neurological disease Involvement plan conduct study</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>